Marksans Pharma arm wins UK nod for high blood pressure drug Moxonidine

Marksans Pharma’s UK subsidiary Relonchem has received marketing authorisation for moxonidine tablets used to treat high blood pressure.

Leave a Reply

Your email address will not be published. Required fields are marked *